In two papers (Finn et al., 1961 ; Clarke et al., 1963) we described experiments which were successful in preventing Rh immunization in Rh-negative male volunteers. The basis of the procedure was to remove rapidly from the circulation previously injected chromium-tagged Rh-positive red cells by giving hightitre incomplete anti-D either as an infusion of plasma or as gamma2-globulin. The remaining five females acted as controls and received no antibody. The procedure was repeated three and six months later. Serum was obtained from the subjects at these times and again at least six months after the last stimulus, and was tested for the presence of complete and incomplete immune antibodies.
In two papers (Finn et al., 1961 ; Clarke et al., 1963) we described experiments which were successful in preventing Rh immunization in Rh-negative male volunteers. The basis of the procedure was to remove rapidly from the circulation previously injected chromium-tagged Rh-positive red cells by giving hightitre incomplete anti-D either as an infusion of plasma or as gamma2-globulin. In our second paper we stated that the next steps should be to find out whether foetal red cells could be cleared equally well as adult and whether female volunteers could be protected in the same way as men. The results of experiments to test these points form the first part (I) of the present paper. The second part (II) concerns two factors of great importance in the application of the technique to preventing Rh immunization due to pregnancy. These are the frequency with which transplacental haemorrhage from foetus to mother occurs during pregnancy as distinct from at delivery, and the relation of the production of immune antibodies to the size of transplacental haemorrhage assessed after delivery. In the third part of the paper (III) we discuss some of the details of the clinical trial, recently started in Liverpool, of anti-D gamma2-globulin injection given to Rh-negative women after delivery.
I. Clearance of Rh-positive Foetal Cells in Women and its Relation to the Production of Immune Anti-D Material and Methods.-Ten female Rh-negative blooddonor volunteers (all nulliparous and post-menopausal) took part in the experiment. Each was injected intravenously with 5 ml. of Rh-positive ABO-compatible foetal blood obtained from the umbilical veins of three babies. The actual Rh genotype of the injected blood varied on different occasions. Survival of the Rh-positive foetal cells was measured either by tagging them with 5tCr or by using the Kleihauer acid-elution technique, which enables foetal cells to be demonstrated and counted among a population of adult red cells (Kleihauer and Betke, 1960) . We counted the number of foetal cells in 50 lowpower fields (diameter 940 1u) in each of two slides, and the average of the two counts was taken as the foetal-cell score. Where this resulted in a fraction the next higher digit was taken as the score. Half an hour after the injection of the Rh-positive red cells five of the volunteers received an intramuscular injection of S ml. of gamma,-globulin prepared by the Blood Products Laboratory of the Lister Institute from the pooled sera of 11 hyperimmunized male volunteers. The anti-D titre of this gamma,-globulin was 1 in 262,000 by the indirect Coombs test.
The remaining five females acted as controls and received no antibody. The procedure was repeated three and six months later. Serum was obtained from the subjects at these times and again at least six months after the last stimulus, and was tested for the presence of complete and incomplete immune antibodies.
Results
The results are shown in Table I , from which it will be seen that in each of the treated volunteers the foetal cells were rapidly cleared from the circulation by the anti-D gamma2-globulin. In the controls, on the other hand, the foetal scores generally remained much higher, though there are some results Vol. anti-D gamma2-globulin after each stimulus 5 ml.
5 ml. 5 ml. (1) Timing of Transplacental Haemorrhage in Relation to
Labour
We examined for foetal cells samples of blood from 200 mothers (random for blood group) before and after parturition, the "before" samples being taken anything from a few hours to a few days before the onset of labour and the " after " ones within 48 hours of it. Table II gives the results, and it will be seen that in 135 cases no foetal cells were observed either before or after delivery. In about two-thirds of the cases (40 out of 59) where foetal cells were detected after delivery they had not been present just before. In 19 out of the 59 cases, foetal cells were present both before and after delivery, but in four of these the number of cells was appreciably greater after parturition. In only six cases were foetal cells present before delivery and absent afterwards. Unfortunately we do not know the ABO blood group of the babies, but the data are still informative. Bleeds which have occurred early in pregnancy may no longer be present in our pre-delivery sample if the baby is ABOincompatible with the mother. On the other hand, if they have occurred at delivery, they may still be present in the afterdelivery specimens, as some of these were taken very soon after the birth of the baby. This biases the data slightly by magnifying the importance of labour as a cause of transplacental haemorrhage. However, in the pre-delivery specimens there will be an accumulation of foetal cells deriving from the ABOcompatible cases, and this will argue in the opposite direction by minimizing the importance of labour as a cause of transplacental haemorrhage. Although we cannot allow for the two opposing biases we can say categorically that in the 59 samples of blood where foetal cells were present after delivery 40 of the haemorrhages had occurred during labour (or at any rate after the date of the pre-delivery sampling). In other words, the finding of foetal cells after delivery indicates in twothirds of our cases that recent transplacental haemorrhage has occurred.
(2) Relation of Transplacental Haemorrhage to Subsequent Immunization We next, in a new series, consider the relation of transplacental haemorrhage detected after delivery to the subsequent production of immune antibodies, and our work on this is still in progress. Using five Liverpool maternity units, blood samples are being taken from Rh-negative primiparae after delivery and foetal-cell scores made. Where the baby is Rhpositive, samples of serum are then obtained from the mother three and six months later (and wherever possible in a subsequent pregnancy) and tested for antibodies. The results for 216 ABO-compatible pregnancies followed up at three months, and for 126 of these for which information at six months is available, are set out in Table III , which shows that the inci-dence of immune-antibody formation increases with the number of foetal cells found. However, the subdivisions of the cell count in Table III are arbitrary, and we have therefore presented the data in a more absolute way (Table IV) . Here only the presence or absence of foetal cells is considered in relation to antibody formation, and it will be seen that there is a highly significant relation between the presence of foetal cells in the post-delivery sample and the production of immune antibody (P=0.0053 using the test at three months, and P=0.0046 using the latest antibody test in each case). The basic data from which these tables are derived are given in the Appendix. Our information also suggests that there is an increased probability of producing immune antibodies the greater the size of the haemorrhage, and the graph shows the weighted regression of antibody production on foetal-cell score. It will be seen that the y axis (percentage producing antibodies) has been transformed to angles and the x axis (foetal-cell score) to the square root of the cell score. This is because the direct relation between the two parameters was non-linear, but with the square-root transformation the relation became linear or almost linear over the range investigated. The weighted regression of antibody production on foetal-cell score is highly significant (P<0.001).
It will be seen from Table III that three patients developed immune antibodies even though we detected no foetal cells. We do not know (a) whether we failed to detect cells which were in fact present, (b) whether the cells had already disappeared after an ante-partum transplacental haemorrhage, or (c) whether immunization was due to some cause other than the transplacental haemorrhage. We do not believe that the lastmentioned possibility is at all likely, and only further study of successive samples throughout pregnancy will decide how often foetal cells disappear during the ante-partum period.
Data on ABO incompatibility in relation to Rh-antibody formation are given in Table V. They show the incidence of antibody formation in our series when the pregnancies are divided according to whether or not the foetus is ABOcompatible with the mother. It will be seen that at three months no mother whose baby was incompatible on the ABO system has produced Rh antibodies. This These experiments, however, represent an artificial situation, and the problem is whether the method is applicable in preventing Rh immunization due to pregnancy. The crux of the matter is the time at which the immunizing transplacental haemorrhage takes place, and the evidence provided by us on the one hand and that by Cohen and Zuelzer (1964) Cases for the trial are chosen from the patients of five maternity units in Liverpool in co-operation with their medical staffs. The units are visited in the morning of each week-day, and a sample of blood is obtained from all Rh-negative women just delivered of their first babies. Films from these samples are immediately eluted and stained and counts of the number of foetal cells are made. Where the foetal-cell score is five or more and where the corresponding cord blood is Rh-positive and ABO-compatible with the mother, the case is included in the trial. Alternate cases are given, within 36 hours of delivery, 5 ml. of gamma2-globulin containing high-titre (1:262,000 by indirect Coombs test) anti-D by intramuscular injection. The other cases are treated as controls and given no anti-D.
The patients are being followed up three and six months after delivery, when samples of blood are taken and tested for immune antibodies. Every effort is also being made to keep these women under observation when they become pregnant for a second time, since antibody formation sometimes becomes apparent only through the stimulus of a second pregnancy. We do not expect that significant results will be available until 1966, but after five months (November 1964) three out of eight of the controls have produced immune antibodies. Had the finding of an appreciable foetal-cell score after delivery made no difference to the probability of sensitization it is unlikely that there would have been any antibodies at all in such a small number of cases. In contrast, none of the six treated cases so far followed up has as yet presented any evidence of immune anti-D formation, although they all show a very weak indirect Coombs reaction consistent with the persistence of the administered anti-D, which we have previously been able to detect up to six months after injection. Further follow-up will be necessary to establish with certainty that these cases have not been immunized. On three occasions we gave 10 Rh-negative post-menopausal nulliparae 5 ml. of Rh-positive foetal blood intravenously. In five of them each infusion was followed by an intramuscular injection of 5 ml. of anti-D gamma2-globulin, and in each case this resulted in the foetal cells being rapidly cleared from the woman's circulation.
The other five women did not receive the anti-D gammaglobulin and served as controls. One of these controls and none of the treated women developed immune anti-D, a result which, though it does not demonstrate that protection was achieved, does rule out the possibility of this technique enhancing antibody production.
To find out if there is any relation between transplacental haemorrhage and labour, blood samples were taken from 200 women during the week preceding and the 48 hours following labour. Tests for foetal cells showed that in 135 patients none was present either before or after labour. Of the 65 where transplacental haemorrhage had occurred, in six this had taken place before labour and had disappeared after it. In 19 patients cells were present both before and after delivery, and in 40-that is, two-thirds-cells were not there before delivery but were present afterwards. We therefore consider that the majority of cases of transplacental haemorrhage occurred during labour or very shortly before it. Forty-seven haemorrhages were estimated to be less than 0.25 ml. of foetal blood in the maternal circulation, and of the 18 larger foetal haemorrhages 14 (78%) had occurred during or just before labour.
To find out if there is any relation between the presence of foetal cells in the maternal circulation after delivery and subsequent Rh immunization, a new series of Rh-negative primiparae is being examined for foetal cells in the maternal circulation after delivery, and if the baby is Rh-positive the serum of the women is being tested for antibodies three and six months later. Out of 216 women tested, no foetal cells were found in 135, and three of these developed anti-D; of 81 women in whom foetal cells were found, 10 developed anti-D. There is thus a statistically significant relation between the detection of foetal cells and subsequent antibody production (P = 0.005); moreover, the greater the number of foetal cells found the greater is the likelihood of immunization. A possible reason why Cohen and Zuelzer (1964) failed to find this relation is discussed.
Some details of the design and organization of a clinical trial of anti-D in selected women are given. For the trial the number of foetal cells after delivery is being used to detect Rh-negative primiparae " at risk" of Rh immunization, and alternate cases of such women are being given 5 ml. of intramuscular gamma,-globulin with a high anti-D titre immediately after the birth of the baby. At the time of writing, this clinical trial has been in progress for only five months, but already the three-month follow-up shows that none of the six protected cases has any evidence of immune-antibody formation, while three out of eight untreated controls have produced immune anti-D. This preliminary result not only encourages the hope that a considerable proportion of Rh immunization can be prevented, but, in addition, it provides confirmatory evidence that women with a high risk of Rh immunization can be detected after delivery by examination of their blood for foetal cells.
In a note on the Kleihauer technique for the detection of foetal cells attention is drawn to the fact that certain women cannot be scored for the presence or absence of these because their blood contains not only large numbers of cells which look like foetal ones but also large numbers which are intermediate between adult and foetal cells in appearance. It 
